-
Start Preamble
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as a sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group, Diabetes, Endocrinology and Metabolic Diseases B Subcommittee.
Date: March 5-6, 2008,
Open: March 5, 2008, 8 a.m. to 8:30 a.m.
Agenda: To review procedures and discuss policy.
Place: Legacy Hotel & Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.
Closed: March 5, 2008, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Legacy Hotel & Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.
Closed: March 6, 2008, 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: Legacy Hotel & Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.
Contact Person: John F. Connaughton, PhD, Chef, Chartered Committees Section, Review Branch, DEA, NIDDK, National Institutes of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7797, connaughtonj@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research, 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)
Start SignatureDated: January 30, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-501 Filed 2-5-08; 8:45 am]
BILLING CODE 4140-01-M
Document Information
- Published:
- 02/06/2008
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 08-501
- Dates:
- March 5-6, 2008,
- Pages:
- 6984-6984 (1 pages)
- PDF File:
- 08-501.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute